Published: Jul 01, 2021
CRISPR and Cas Genes
Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global CRISPR and Cas genes market was valued at US$ 7,234.5 Mn by 2026, expanding at a CAGR of around 20.1% from 2018 to 2026. Increase in applications of CRISPR and Cas gene editing technology in bacteria and usage of gene editing technology for prevention of various diseases are the major factors anticipated to drive the market from 2018 to 2026. Rise in need of alternative medicine for chronic diseases and increase in investments by key players in Asia Pacific are projected to propel the market during the forecast period.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.
The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineering. However, there are several limitations, which need consideration before clinical applications. Further, many researchers are working on the limitations of CRISPR gene editing technology for better results. The potential of CRISPR gene editing to alter the human genome and modify the disease conditions is incredible but exists with ethical and social concerns.
Search jobs Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results
SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) #DNA Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020.
“We reported a strong quarter both for orders and revenue, building a solid foundation for fiscal 2021,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We see early evidence that our investment in synbio products for our pharmaceutical and biotech customers is beginning to gain traction, and for our NGS tools business, our liquid biopsy customers continue to drive revenue growth. Both our biopharma and DNA data storage teams made progress in advancing technologies, and we strengthened our balance sheet with $324 million
CRISPR and CAS Gene Market to Score Past US$ 7,603 8 Million Valuation by 2027: CMI – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Search jobs 21-Dec-2020 CRISPR and CAS Gene Market to Garner US$ 7,603.8 Million, with a CAGR of 20.8% by 2026, Global Industry Analysis By Overview, Size, Growth, Share, Trends, Top Leaders, Regional Statistics
Global CRISPR and CAS Gene Market – Insights
CRISPR technology is a simple tool, which is used for gene editing. It is a powerful nucleic acid-targeting editing tools for genome, which allows researchers to easily alter DNA sequences and modify gene function. In this technology, protein Cas9 or CRISPR, which is an enzyme that acts as a pair of molecular scissors that is capable of cutting strands of DNA. It has many potential applications including correcting genetic defects, treating and preventing the spread of diseases, and improving crops. It is faster, cheaper, and more precise than previous techniques of editing DNA like ZFNs (Zinc Finger Nucleases) and TALENs (Transcription Activator-Like Effector Nucleases). Researc